5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 10.49▼ | 10.49▼ | 10.49▼ | 10.46▲ | 10.45▲ |
MA10 | 10.45▲ | 10.45▲ | 10.45▲ | 10.46▲ | 10.43▲ |
MA20 | 10.42▲ | 10.42▲ | 10.42▲ | 10.44▲ | 10.40▲ |
MA50 | 10.33▲ | 10.30▲ | 10.30▲ | 10.42▲ | 10.23▲ |
MA100 | N/A | N/A | N/A | 10.39▲ | N/A |
MA200 | N/A | N/A | N/A | 10.26▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.004▲ | 0.002▲ | 0.002▲ | 0.003▲ | -0.003▼ |
RSI | 74.753▲ | 75.150▲ | 75.248▲ | 62.942▲ | 86.126▲ |
STOCH | 93.723▲ | 93.723▲ | 93.723▲ | 8.538▼ | 47.491 |
WILL %R | -23.077▲ | -23.077▲ | -23.077▲ | -86.667▼ | -79.677▼ |
CCI | 75.029 | 75.057 | 75.057 | 43.614 | 89.092 |
Tuesday, September 30, 2025 05:14 AM
Partnership combines Secarna’s OligoCreator® platform with VERAXA’s technology suite to create next-generation targeted therapies for autoimmune and inflammatory diseasesZURICH, SWITZERLAND, and ...
|
Tuesday, September 30, 2025 05:02 AM
September 30, 2025 -- VERAXA Biotech, an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp. (NASDAQ:VACH, ...
|
Tuesday, September 30, 2025 05:02 AM
September 30, 2025 -- VERAXA Biotech, an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp. (NASDAQ:VACH, ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
30/09/25 | 10.45 | 10.496 | 10.45 | 10.496 | 2,000 |
29/09/25 | 10.45 | 10.45 | 10.45 | 10.45 | 1,000 |
26/09/25 | 10.46 | 10.46 | 10.46 | 10.46 | 1,100 |
25/09/25 | 10.45 | 10.45 | 10.45 | 10.45 | 1,500 |
24/09/25 | 10.48 | 10.50 | 10.45 | 10.456 | 3,000 |
23/09/25 | 10.45 | 10.99 | 10.45 | 10.50 | 2,300 |
22/09/25 | 10.45 | 10.45 | 10.45 | 10.45 | 1,300 |
19/09/25 | 10.43 | 10.43 | 10.43 | 10.43 | 1,400 |
18/09/25 | 10.43 | 10.45 | 10.42 | 10.45 | 3,700 |
17/09/25 | 10.44 | 10.44 | 10.44 | 10.44 | 1,500 |
|
|
||||
|
|
||||
|
|